Literature DB >> 35590404

Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy.

Wei Jiang1,2,3, Lulu Wei3, Bing Chen1, Xingyu Luo1,2, Peipei Xu4, Jianfeng Cai5, Yong Hu6.   

Abstract

Entities:  

Year:  2022        PMID: 35590404      PMCID: PMC9118707          DOI: 10.1186/s12951-022-01418-5

Source DB:  PubMed          Journal:  J Nanobiotechnology        ISSN: 1477-3155            Impact factor:   9.429


× No keyword cloud information.

Correction to: Journal of Nanobiotechnology (2022) 20:129 https://doi.org/10.1186/s12951-022–01322-y

Following publication of the original article [1], the author reported that the corresponding author symbols were omitted from the author group. Dr. Jianfeng Cai and Peipei Xu have been added to the author group and are presented correctly in this correction article. There are 3 corresponding authors, including Ms. Yong Hu (hvyong@nju.edu.cn), Jianfeng Cai (jianfengcai@usf.edu) and Peipei Xu (xu_peipei0618@163.com). The original article [1] has been corrected.
  1 in total

1.  Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy.

Authors:  Wei Jiang; Lulu Wei; Bing Chen; Xingyu Luo; Peipei Xu; Jianfeng Cai; Yong Hu
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.